![]() |
|||||||||||||
|
All | Since 2019 | |
Citation | 5450 | 3969 |
h-index | 23 | 20 |
i10-index | 134 | 84 |
CORRECTION OF ANEMIA WITH ERYTHROPOIESIS STIMULATING AGENTS IN CHRONIC KIDNEY DISEASE PATIENTS
Nanditha Shree H.*, Hakash R., Preethi M. S. and Nimishambha K. S.
ABSTRACT
CKD is a condition in which the kidneys are damaged and cannot filter blood as well as they should, anemia is one of the common complications of CKD. The preferred method of treating anemia caused by CKD is iron supplementation and ESAs. A descriptive study on Correction of Anemia with Erythropoiesis Stimulating Agents in Chronic kidney disease. This was a descriptive study performed on 180 patients, in the Nephrology department, Sagar hospital. It was assessed and evaluated by a suitable statistical tool. Results: Among 180 patients, 121(67.2%) were males and 59 (67.2%) were females, and more patients were observed in the age group >60. Hypertension (93.8%), DM (82.7), Hypothyroidism (75.5%) had the highest prevalence rate of risk factors. First generation ESAs were most commonly prescribed (90%) and most effective ESA compared to Keywords: CKD, Anemia, Effectiveness, Efficacy, ESA. [Download Article] [Download Certifiate] |